The Role of Surgery in Metastatic Renal Cell Carcinoma in 2024
Renal cell carcinoma (RCC) is the most Collections common solid tumour of the kidney and accounts for 3% of all cancers.While immune checkpoint inhibitor (ICI)-based combination therapies have emerged as the first-line treatment for metastatic renal cell carcinoma (mRCC), the role of surgery has become more controversial.This review summarizes the